Inke S.A: APIs manufacturing plant.
01 1Inke SA
02 1Neuland Laboratories Limited
01 1INDACATEROL MALEATE
02 1Indacaterol Maleate
01 1India
02 1Spain
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0024
Start Marketing Date : 2021-01-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Neuland Laboratories- A dedicated 100% API provider.
NDC Package Code : 58032-1025
Start Marketing Date : 2019-11-13
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Indacaterol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indacaterol, including repackagers and relabelers. The FDA regulates Indacaterol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indacaterol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Indacaterol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Indacaterol supplier is an individual or a company that provides Indacaterol active pharmaceutical ingredient (API) or Indacaterol finished formulations upon request. The Indacaterol suppliers may include Indacaterol API manufacturers, exporters, distributors and traders.
click here to find a list of Indacaterol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Indacaterol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Indacaterol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Indacaterol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Indacaterol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Indacaterol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Indacaterol suppliers with NDC on PharmaCompass.
We have 2 companies offering Indacaterol
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
